Absalon Gutierrez MD

Diabetes, Lipid Metabolism

Physician

6410 Fannin StSte 600Houston, TX 77030
Phone+1 713-325-7161
Fax+1 713-500-6647

Dr. Gutierrez is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gutierrez's full profile Already have an account?

Summary

Absalon D. Gutierrez, MD, is an endocrinologist based in Houston, TX, with the particular interests in diabetes and obesity. He completed his education and residency in Internal Medicine at the University of New Mexico School of Medicine and a fellowship in Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine. Dr. Gutierrez also has broad experience in general endocrinology, including thyroid disorders and atherosclerosis. His publications, mostly focused on diabetes and obesity topics, have been acknowledged by other academics multiple times. He has led clinical trials investigating GLP-1 therapy and the effects of antidiabetic medications on prediabetes.

Education & Training

Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2012
University of New Mexico School of MedicineResidency, Internal Medicine, 2006 - 2009
University of New Mexico School of MedicineClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2011 - 2027
NM State Medical License 2006 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017

Clinical Trials

Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
COMPLETED
PHASE4
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response Start of enrollment: 2020 May 15
COMPLETED
PHASE4
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Diminished arginine bioavailability during hyperglycaemia distinguishes individuals with Aβketosis-prone diabetes from those with type 2 diabetes: implications for the...
Jean W Hsu, Adriana Elizondo, Absalon Gutierrez, Eunice Caducoy, Mustafa Tosur
Diabetologia. 2026-08-14
Integrated Genomic and Transcriptomic Study Revealsandas Important Obesity Susceptibility Genes in a High-Risk Hispanic/Latino Population.
Daeeun Kim, Hannah G Polikowsky, Heather M Highland, Hung-Hsin Chen, Wanying Zhu
Circulation. Genomic and Precision Medicine. 2026-08-01
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.
Luba Yammine, Francesco Versace, Charles E Green, Heather E Webber, Jin Ho Yoon
BMJ Open. 2026-05-20

Press Mentions

From Shock to Action: Navigating the First Diabetes Discussion with PatientsMay 14th, 2025
What’s Your Go-to Treatment for New Diabetes Patients?May 7th, 2025
Cheap Generic Drug Slashes Knee Pain in New StudyApril 29th, 2025

Grant Support

The Pharmacogenetics of Weight Cycling with GLP-1 Receptor AgonistsUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2026–2031
R01 - Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with PrediabetesNIH2021–2027
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with PrediabetesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with PrediabetesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with PrediabetesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026